Matthew M Y Lee currently works at the School of Cardiovascular & Metabolic Health, University of Glasgow. Matthew does research in Clinical Trials, Cardiology, Heart Failure, Cardiomyopathy, Diabetes and Obesity. His current projects include SUGAR-DM-HF, SEQUOIA-HCM and DAPA-RESIST. He is on the clinical event committee for FINEARTS-HF and REVIVED-BCIS2. He is co-/sub-investigator in STEP-HFpEF, IRONMAN, REALIZE-K, SOUL, CMR GUIDE, DAPA-HF, PARADISE-MI, PARAGON-HF, CABG-ACS and FAMOUS-NSTEMI.